Lifestyle Intervention to Treat Diabetes in the Marshall Islands
Status
Conditions
Treatments
Study type
Funder types
Identifiers
Details and patient eligibility
About
The Republic of the Marshall Islands has the highest prevalence of type 2 diabetes (T2D) in the world. This clinical trial tested whether a community-based, intensive, plant-rich lifestyle intervention with exercise is more effective for treating and managing T2D in the Republic of the Marshall Islands than the standard of diabetes care. The intensive lifestyle intervention consisted of a plant-rich diet and moderate exercise. It centered around a 12-week program of counseling and instruction on healthy eating, exercise, and stress management, as well as hands-on cooking classes and prepared meals. Cardiometabolic outcomes were assessed throughout the intervention and at 24 weeks. The present study is the first randomized clinical trial ever conducted in the Republic of the Marshall Islands and the first lifestyle intervention trial conducted in Micronesia.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
- Resident of the Republic of Marshall Islands
- Aged 18 - 75 years
- HbA1c ≥ 8.0% or diagnosed with T2D and taking diabetes medication
- Medical clearance to participate from Diabetes Wellness Center (DWC) physicians.
Exclusion criteria
- Recent (≤3 months) change in a diabetes-related medication dosage
- A physical or medical condition that would impede participation in the lifestyle intervention (e.g., wheel-chair bound, unstable angina)
- Evidence of significant coronary heart disease
- Previous participation in an intensive lifestyle intervention
Trial design
Primary purpose
Allocation
Interventional model
Masking
138 participants in 2 patient groups
Trial contacts and locations
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal